Latest Articles

Publication Date
Endometriosis Treatment Drugs Market Expected to Hit USD 16.6 Billion by 2032 with a Remarkable 4.91% CAGR - ABN Newswire

Endometriosis Treatment Drugs Market Expected to Hit USD 16.6 Billion by 2032 with a Remarkable 4.91% CAGR ABN Newswire

Published: Jan. 21, 2025, 12:38 a.m.
17 cancer symptoms you should never ignore as record number of people living with disease - Surrey Live

17 cancer symptoms you should never ignore as record number of people living with disease Surrey Live

Published: Jan. 21, 2025, 12:01 a.m.
Dr Vetter on the Role of Trial Inclusion Criteria on Coverage for Pembrolizumab- and Dostarlimab-Based Regimens in Endometrial Cancer - OncLive

Dr Vetter on the Role of Trial Inclusion Criteria on Coverage for Pembrolizumab- and Dostarlimab-Based Regimens in Endometrial Cancer OncLive

Published: Jan. 20, 2025, 9:34 p.m.
Dostarlimab Combo Earns Expanded European Approval in Endometrial Cancer - Cancer Network

Dostarlimab Combo Earns Expanded European Approval in Endometrial Cancer Cancer Network

Published: Jan. 20, 2025, 5:08 p.m.
Lab tech firm BioGrad opening £25m women's health centre - Business Live

Lab tech firm BioGrad opening £25m women's health centre Business Live

Published: Jan. 20, 2025, 2 p.m.
BBC The Traitors star opens up about dealing with crippling condition while on show - Surrey Live

BBC The Traitors star opens up about dealing with crippling condition while on show Surrey Live

Published: Jan. 20, 2025, 1:07 p.m.
'Two things that helped my crippling health condition on BBC's The Traitors' - Yahoo News UK

'Two things that helped my crippling health condition on BBC's The Traitors' Yahoo News UK

Published: Jan. 20, 2025, 1:04 p.m.
GSK’s Jemperli combination approved by EC for expanded endometrial cancer use - PMLiVE

GSK’s Jemperli combination approved by EC for expanded endometrial cancer use PMLiVE

Published: Jan. 20, 2025, 12:33 p.m.
GSK’s Jemperli gains EU approval for advanced endometrial cancer treatment - DirectorsTalk Interviews

GSK’s Jemperli gains EU approval for advanced endometrial cancer treatment DirectorsTalk Interviews

Published: Jan. 20, 2025, 7:28 a.m.
GSK’s Jemperli Gains Expanded EU Approval for Broader Endometrial Cancer Treatment - TipRanks

GSK’s Jemperli Gains Expanded EU Approval for Broader Endometrial Cancer Treatment TipRanks

Published: Jan. 20, 2025, 7:19 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!